Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenting Zheng

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Toxics|April 26, 2024
Neurotoxicity of Combined Exposure to the Heavy Metals (Pb and As) in Zebrafish (<i>Danio rerio</i>)Ming Liu, Ping Deng, Guangyu Li, et al.
Bioactive Materials|March 23, 2023
Functionalization of <i>in vivo</i> tissue-engineered living biotubes enhance patency and endothelization without the requirement of systemic anticoagulant administrationHongyu Yan, Quhan Cheng, Jianghua Si, et al.
Journal of Leukocyte Biology|January 21, 2014
A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cellsSiyuan Xia, Jun Wei, Jingya Wang, et al.
Nature Medicine|April 29, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trialHuiyuan Li, Yuan Xu, Yunfei Chen, et al.
Nature|December 13, 2019
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapyJun Wei, Lingyun Long, Wenting Zheng, et al.
Nature Communications|July 20, 2023
Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1Yuchen Gao, Ying Chi, Yunfei Chen, et al.
Annals of Hematology|August 14, 2022
The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuriaBing Han, Jiang Ji, Bo Zhang, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphomaWei Liu, Wei Liu, Hesong Zou, et al.
Blood Advances|April 21, 2022
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C Talleur, Amr Qudeimat, Jean-Yves Métais, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Toxics|April 26, 2024
Neurotoxicity of Combined Exposure to the Heavy Metals (Pb and As) in Zebrafish (<i>Danio rerio</i>)Ming Liu, Ping Deng, Guangyu Li, et al.
Bioactive Materials|March 23, 2023
Functionalization of <i>in vivo</i> tissue-engineered living biotubes enhance patency and endothelization without the requirement of systemic anticoagulant administrationHongyu Yan, Quhan Cheng, Jianghua Si, et al.
Journal of Leukocyte Biology|January 21, 2014
A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cellsSiyuan Xia, Jun Wei, Jingya Wang, et al.
Nature Medicine|April 29, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trialHuiyuan Li, Yuan Xu, Yunfei Chen, et al.
Nature|December 13, 2019
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapyJun Wei, Lingyun Long, Wenting Zheng, et al.
Nature Communications|July 20, 2023
Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1Yuchen Gao, Ying Chi, Yunfei Chen, et al.
Annals of Hematology|August 14, 2022
The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuriaBing Han, Jiang Ji, Bo Zhang, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphomaWei Liu, Wei Liu, Hesong Zou, et al.
Blood Advances|April 21, 2022
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C Talleur, Amr Qudeimat, Jean-Yves Métais, et al.
Pageof 5